CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2016		Dec. 31, 2015
CURRENT ASSETS
Cash and cash equivalents	$ 27,702		$ 42,229
Available for sale securities	619		753
Trade accounts and grants receivable, net	783		1,078
Landlord receivable	156		567
Prepaid expenses and other current assets	1,787		2,610
Total current assets	31,047		47,237
Property, plant and equipment, net and construction in progress	4,062		7,539
Deferred license fees	173		322
Deposits and other long-term assets	1,022		1,299
Equity method investment in Asterias, at fair value (Note 4)	52,194		0
Equity method investment in Ascendance	4,338		4,671
Intangible assets, net	11,491	[1]	33,592
TOTAL ASSETS	104,327		94,660
CURRENT LIABILITIES
Accounts payable and accrued liabilities	6,508	[1]	9,377
Capital lease liability, current portion	173		38
Promissory notes, current portion	95		95
Deferred grant income	0		2,513
Deferred license and subscription revenue, current portion	627		439
Total current liabilities	7,403		12,462
LONG-TERM LIABILITIES
Deferred revenues, net of current portion	462		615
Deferred rent liabilities, net of current portion	28		158
Lease liability	1,386		4,400
Related party convertible debt, net of discount	701		324
Promissory notes, net of current portion	173		220
Capital lease, net of current and other liabilities	122		34
TOTAL LIABILITIES	10,275		18,213
Commitments and contingencies (Note 13)
SHAREHOLDERS' EQUITY
Preferred shares, no par value, 2,000 shares authorized; none issued and outstanding	0		0
Common shares, no par value, 150,000 shares authorized; 102,288 shares issued and 101,668 shares outstanding at June 30, 2016; 94,894 issued and 90,421 outstanding at December 31, 2015	310,881		274,342
Accumulated other comprehensive income (loss)	(504)		(237)
Accumulated deficit	(221,743)		(229,181)
Treasury stock at cost: 620 shares at June 30, 2016 and 4,473 shares at December 31, 2015	(2,891)		(18,033)
BioTime, Inc. shareholders' equity	85,743		26,891
Non-controlling interest	8,309		49,556
Total shareholders' equity	94,052		76,447
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 104,327		$ 94,660

[1] Reflects the effect of the Deconsolidation.